✦ LIBER ✦
PD-081 A phase 2 randomized study of GM-CSF gene-modifiedautologous tumor vaccine (CG8123) with and without low-dose cyclophosphamide in advanced stage non-small cell lung cancer (NSCLC)
✍ Scribed by Schiller, J.; Nemunaitis, J.; Ross, H.; Jablons, D.; Harper, H.; Sterman, D.; Kelly, K.; Carbone, D.; Lin, A.; Hege, K.
- Book ID
- 118572828
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 276 KB
- Volume
- 49
- Category
- Article
- ISSN
- 0169-5002
No coin nor oath required. For personal study only.